T h e J o u r n a l o f E x p e r i m e n t a l M e d i c i n e
Coa subdomains D1 or R recognized by mAb 5D5 and 3B3, respectively as shown in Table S1 . c Affinity was determined by ELISA as the association constant (K a ) in nM −1 for each protein domain. Blood from human volunteers was anticoagulated with 10 µg/ml desirudin, dispensed into 0.5-ml aliquots, and inoculated with 5 × 10 6 CFU USA300 LAC. The inoculum was enumerated by lysing blood with 0.5 ml PBS (with 0.5% saponin, 100 U SK K, 50 µg trypsin, 1 µg DNAse, and 5 µg RNAse) prior to plating on agar for CFU enumeration. Serum from coagulated blood of human volunteers was examined by ELISA for the half-maximal IgG titer against purified recombinant proteins derived from of S. aureus Newman genome sequence: α-hemolysin (Hla), D1-D2 domain (D1-D2), or a tandem repeat of the R domain carrying the N12D substitution. c Blood was pretreated with 10 µg CD/ml prior to infection with 5 × 10 6 CFU USA300 LAC.
d Agglutination (%) was calculated from the percent mock-treated CFU after 60 min (without CD) and the staphylococcal load enumerated with SK treatment. e OPK (%) was calculated as the Δ0-60-min load in SK-treated blood without CD treatment.
f Human blood samples were categorized as killer (K), controllers (C), or prey (P) of MRSA isolate USA300 LAC. g Blood samples were lysed after 60 min at 37°C with 0.5 ml PBS (0.5% saponin, 1 µg DNAse, and 5 µg RNAse), followed by CFU enumeration. Data were averaged from two independent determinations. SEM and percent amount of total (60-min SK-treated sample) were calculated. h Blood samples were lysed after 60 min at 37°C with 0.5 ml PBS (0.5% saponin, 100 U SK, 50 µg trypsin, 1 µg DNAse, and 5 µg RNAse), followed by CFU enumeration. Data were averaged from two independent determinations, and SEM and percentage of inoculum (0 min = 5 × 10 6 CFU) were calculated.
